- Home
- ZG vs SMMT Comparison
ZG vs SMMT Comparison
Compare ZG & SMMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZG
- SMMT
- Stock Information
- Founded
- ZG 2004
- SMMT 2003
- Country
- ZG United States
- SMMT United States
- Employees
- ZG N/A
- SMMT N/A
- Industry
- ZG Business Services
- SMMT Biotechnology: Pharmaceutical Preparations
- Sector
- ZG Consumer Discretionary
- SMMT Health Care
- Exchange
- ZG Nasdaq
- SMMT Nasdaq
- Market Cap
- ZG 13.3B
- SMMT 14.5B
- IPO Year
- ZG 2011
- SMMT N/A
- Fundamental
- Price
- ZG $70.73
- SMMT $18.31
- Analyst Decision
- ZG Buy
- SMMT Strong Buy
- Analyst Count
- ZG 24
- SMMT 4
- Target Price
- ZG $67.73
- SMMT $34.75
- AVG Volume (30 Days)
- ZG 609.7K
- SMMT 2.1M
- Earning Date
- ZG 11-06-2024
- SMMT 10-30-2024
- Dividend Yield
- ZG N/A
- SMMT N/A
- EPS Growth
- ZG N/A
- SMMT N/A
- EPS
- ZG N/A
- SMMT N/A
- Revenue
- ZG $2,156,000,000.00
- SMMT N/A
- Revenue This Year
- ZG $17.28
- SMMT N/A
- Revenue Next Year
- ZG $13.99
- SMMT N/A
- P/E Ratio
- ZG N/A
- SMMT N/A
- Revenue Growth
- ZG 13.12
- SMMT N/A
- 52 Week Low
- ZG $36.38
- SMMT $1.88
- 52 Week High
- ZG $73.89
- SMMT $33.89
- Technical
- Relative Strength Index (RSI)
- ZG 65.15
- SMMT 41.16
- Support Level
- ZG $70.51
- SMMT $19.01
- Resistance Level
- ZG $73.89
- SMMT $22.53
- Average True Range (ATR)
- ZG 2.81
- SMMT 1.45
- MACD
- ZG 1.26
- SMMT -0.21
- Stochastic Oscillator
- ZG 83.20
- SMMT 4.85
About ZG Zillow Group Inc.
Zillow Group Inc is an Internet-based real estate company that offers its customers an on-demand experience for selling, buying, renting, or financing with transparency and ease The group works with real estate agents, brokers, builders, property managers, and landlords to pair technology with top-notch service. The group has brands such as Zillow, Trulia, StreetEasy, Hotpads, Zillow Rentals, Zillow Home Loans, ShowingTime, Follow Up Boss, Aryeo and others.
About SMMT Summit Therapeutics Inc.
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.